2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
dei: Entity Common Stock Shares Outstanding | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Weighted Average Number Of Diluted Shares Outstanding | NA | 35.78 | 35.77 | 35.72 | NA | 37.66 | 37.64 | 38.14 | NA | 37.48 | |
Weighted Average Number Of Shares Outstanding Basic | NA | 35.78 | 35.77 | 35.72 | NA | 35.58 | 35.55 | 35.49 | NA | 35.20 | |
Earnings Per Share Basic | -0.85 | -0.90 | -0.96 | -0.44 | 0.58 | 0.03 | 0.16 | 1.96 | 5.26 | 1.98 | |
Earnings Per Share Diluted | -0.85 | -0.90 | -0.96 | -0.44 | 0.55 | 0.03 | 0.15 | 1.82 | 4.89 | 1.86 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Including Assessed Tax | 0.00 | 0.00 | 0.00 | 12.60 | 53.91 | 19.49 | 41.72 | 152.52 | 240.50 | 104.27 | |
Revenues | 0.00 | 0.00 | 0.00 | 12.60 | 53.91 | 19.49 | 41.72 | 152.52 | 240.50 | 104.27 | |
Operating Expenses | 40.15 | 43.28 | 42.62 | 37.52 | 36.52 | 34.69 | 38.38 | 31.71 | 26.98 | 24.86 | |
Research And Development Expense | 27.78 | 30.64 | 29.19 | 25.60 | 25.42 | 23.93 | 26.91 | 21.10 | 17.39 | 16.10 | |
General And Administrative Expense | 12.37 | 12.64 | 13.44 | 11.93 | 11.10 | 10.76 | 11.47 | 10.62 | 9.60 | 8.76 | |
Operating Income Loss | -40.15 | -43.28 | -42.62 | -24.93 | 17.38 | -15.21 | 3.33 | 120.81 | 213.52 | 79.41 | |
Allocated Share Based Compensation Expense | 7.19 | 7.06 | 6.96 | 5.81 | 5.88 | 5.72 | 5.76 | 4.19 | 4.04 | 3.94 | |
Income Loss From Continuing Operations | -30.55 | -32.24 | -34.30 | -15.55 | 20.45 | 0.99 | 5.63 | 69.58 | 184.87 | 69.64 | |
Income Loss From Continuing Operations Before Income Taxes Domestic | -13.60 | -20.39 | -14.87 | -21.32 | -14.35 | -18.62 | -22.06 | -14.89 | -11.57 | -5.47 | |
Income Loss From Continuing Operations Before Income Taxes Foreign | -14.59 | -13.03 | -18.20 | 6.96 | 37.10 | 16.64 | 30.51 | 134.42 | 235.62 | 77.88 | |
Income Tax Expense Benefit | 2.36 | -1.18 | 1.23 | 1.20 | 2.29 | -2.98 | 2.82 | 49.95 | 39.17 | 2.77 | |
Income Taxes Paid Net | 1.32 | 1.17 | NA | NA | 9.05 | 7.03 | NA | NA | NA | NA | |
Profit Loss | -30.55 | -32.24 | -34.30 | -15.55 | 20.45 | 0.99 | 5.63 | 69.58 | 184.87 | 69.64 | |
Net Income Loss | -30.55 | -32.24 | -34.30 | -15.55 | 20.45 | 0.99 | 5.63 | 69.58 | 184.87 | 69.64 | |
Comprehensive Income Net Of Tax | -30.53 | -32.33 | -35.92 | -17.45 | 22.93 | -8.82 | 4.88 | 69.03 | 175.10 | 78.16 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 667.59 | 677.64 | 703.75 | 728.35 | 754.99 | 777.87 | 814.77 | 850.32 | 884.71 | 922.38 | |
Liabilities | 92.36 | 79.38 | 80.22 | 76.08 | 91.66 | 143.67 | 177.47 | 223.94 | 331.89 | 550.34 | |
Liabilities And Stockholders Equity | 667.59 | 677.64 | 703.75 | 728.35 | 754.99 | 777.87 | 814.77 | 850.32 | 884.71 | 922.38 | |
Stockholders Equity | 575.23 | 598.26 | 623.53 | 652.26 | 663.33 | 634.20 | 637.30 | 626.38 | 552.82 | 372.04 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 550.65 | 619.13 | 614.55 | 615.40 | 628.30 | 768.55 | 804.74 | 840.66 | 874.71 | 914.14 | |
Cash And Cash Equivalents At Carrying Value | 251.18 | 204.13 | 216.21 | 225.36 | 284.80 | 752.24 | 791.86 | 823.98 | 848.54 | 899.77 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 251.45 | 204.40 | 216.48 | 225.60 | 285.04 | 752.47 | 792.15 | 824.28 | 848.84 | 899.90 | |
Short Term Investments | 280.74 | 394.89 | 383.01 | 376.78 | 328.36 | NA | NA | NA | NA | NA | |
Prepaid Expense And Other Assets Current | 12.24 | 13.79 | 11.64 | 12.60 | 12.70 | 11.74 | 8.88 | 12.06 | 14.09 | 8.94 | |
Available For Sale Securities Debt Securities | 381.28 | 440.79 | 461.27 | 481.26 | 446.58 | NA | NA | NA | NA | NA |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 9.08 | 7.34 | 6.48 | 5.85 | 5.58 | 5.12 | 5.29 | 5.29 | 5.04 | 5.03 | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 4.38 | 4.01 | 3.93 | 3.73 | 3.46 | 3.02 | 3.02 | 3.07 | 2.97 | 2.90 | |
Property Plant And Equipment Net | 4.70 | 3.33 | 2.55 | 2.12 | 2.12 | 2.10 | 2.27 | 2.22 | 2.07 | 2.12 | |
Long Term Investments | 100.54 | 45.90 | 78.26 | 104.48 | 118.22 | NA | NA | NA | NA | NA | |
Other Assets Noncurrent | 0.88 | 0.88 | 0.81 | 0.33 | 0.33 | 0.31 | 0.32 | 0.32 | 0.30 | 0.27 | |
Available For Sale Debt Securities Amortized Cost Basis | 381.24 | 442.02 | 462.89 | 481.16 | 446.74 | NA | NA | NA | NA | NA |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 40.01 | 28.22 | 30.02 | 26.36 | 42.00 | 93.83 | 125.39 | 174.25 | 304.12 | 542.23 | |
Accounts Payable Current | 11.29 | 3.42 | 5.23 | 5.69 | 7.66 | 9.60 | 10.92 | 10.60 | 5.14 | 4.71 | |
Accrued Liabilities Current | 7.06 | 22.05 | 21.25 | 17.73 | 19.73 | 11.38 | 13.81 | 14.05 | 17.16 | 12.19 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Lease Liability Noncurrent | 4.81 | 4.81 | 4.43 | 3.76 | 3.84 | 3.73 | 4.03 | 4.46 | 4.57 | 2.38 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 575.23 | 598.26 | 623.53 | 652.26 | 663.33 | 634.20 | 637.30 | 626.38 | 552.82 | 372.04 | |
Common Stock Value | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Additional Paid In Capital | 463.80 | 456.30 | 449.23 | 442.05 | 435.67 | 429.47 | 423.74 | 417.70 | 413.18 | 407.50 | |
Retained Earnings Accumulated Deficit | 124.63 | 155.18 | 187.42 | 221.72 | 237.28 | 216.82 | 215.83 | 210.21 | 140.62 | -44.25 | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -13.24 | -13.26 | -13.17 | -11.55 | -9.64 | -12.12 | -2.31 | -1.57 | -1.02 | 8.75 | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | NA | 7.06 | 6.96 | 5.81 | NA | 5.72 | 5.76 | 4.19 | NA | 3.94 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -13.77 | -33.89 | -29.55 | -26.55 | -27.17 | -29.70 | -30.32 | -24.00 | -58.82 | 605.00 | |
Net Cash Provided By Used In Investing Activities | 61.56 | 22.69 | 20.10 | -31.69 | -445.12 | -0.10 | -0.51 | -0.32 | -0.16 | -0.53 | |
Net Cash Provided By Used In Financing Activities | 0.31 | 0.01 | 0.22 | 0.58 | 1.37 | -0.00 | 0.28 | 0.33 | 2.36 | 0.44 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -13.77 | -33.89 | -29.55 | -26.55 | -27.17 | -29.70 | -30.32 | -24.00 | -58.82 | 605.00 | |
Net Income Loss | -30.55 | -32.24 | -34.30 | -15.55 | 20.45 | 0.99 | 5.63 | 69.58 | 184.87 | 69.64 | |
Profit Loss | -30.55 | -32.24 | -34.30 | -15.55 | 20.45 | 0.99 | 5.63 | 69.58 | 184.87 | 69.64 | |
Increase Decrease In Accounts Payable | 7.62 | -2.07 | -0.41 | -2.10 | -2.64 | -1.04 | 0.98 | 5.46 | 0.52 | -6.50 | |
Share Based Compensation | 7.19 | 7.06 | 6.96 | 5.81 | 5.88 | 5.72 | 5.76 | 4.19 | 4.04 | 3.94 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | 61.56 | 22.69 | 20.10 | -31.69 | -445.12 | -0.10 | -0.51 | -0.32 | -0.16 | -0.53 | |
Payments To Acquire Property Plant And Equipment | 1.40 | 0.75 | 0.70 | 0.12 | 0.12 | 0.08 | 0.51 | 0.23 | 0.16 | 0.53 | |
Payments To Acquire Investments | 97.03 | 54.47 | 86.46 | 52.58 | NA | NA | NA | NA | NA | NA |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 0.31 | 0.01 | 0.22 | 0.58 | 1.37 | -0.00 | 0.28 | 0.33 | 2.36 | 0.44 |
2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 0.00 | 0.00 | 0.00 | 12.60 | 53.91 | 19.49 | 41.72 | 152.52 | 240.50 | 104.27 | |
Revenue From Contract With Customer Including Assessed Tax | 0.00 | 0.00 | 0.00 | 12.60 | 53.91 | 19.49 | 41.72 | 152.52 | 240.50 | 104.27 | |
Adimab L L C, License And Service | 0.00 | 0.00 | 0.00 | 5.40 | 0.00 | 2.00 | 0.00 | 3.40 | 0.00 | 0.00 | |
Glaxo Smith Kline, License And Service | 0.00 | 0.00 | 0.00 | 12.60 | 53.90 | 19.50 | 41.70 | 152.50 | NA | NA |